Hypoxia: Progressive Multiple Myeloma and Its Therapy Resistance
This study critically reviews the role of hypoxia in the progression of Multiple Myeloma (MM)and its therapy resistance. It explains the existence and role played by Hypoxia Inducible Factors (HIF) including HIF-1α and HIF-β in tumor (MM) progression. These HIF are key transcription factors of hypo...
Main Authors: | Ogechi Charity Obayi, Emmanuella Ogbonna, Catherine Chinonye Eleje, Nwabueze Enukaorah Permsec Umerah |
---|---|
Format: | Article |
Language: | English |
Published: |
Research Center for Rational Use of Drugs (RCRUD)
2021-04-01
|
Series: | Journal of Pharmaceutical Care |
Subjects: | |
Online Access: | https://jpc.tums.ac.ir/index.php/jpc/article/view/389 |
Similar Items
-
Different Adaptive Responses to Hypoxia in Normal and Multiple Myeloma Endothelial Cells
by: Irene Filippi, et al.
Published: (2018-03-01) -
Cancer Associated Fibroblasts and Tumor Growth: Focus on Multiple Myeloma
by: Kim De Veirman, et al.
Published: (2014-06-01) -
HLA-DPA1 gene is a potential predictor with prognostic values in multiple myeloma
by: Jie Yang, et al.
Published: (2020-09-01) -
Mandibular Swelling as the First Manifestation of Multiple Myeloma
by: Maryam Amirchaghmaghi, et al.
Published: (2010-12-01) -
Testicular plasmocytoma as an unsual late relapse of multiple myeloma
by: Omar Karray, et al.
Published: (2020-07-01)